Ixekizumab for plaque psoriasis improves work productivity
Ixekizumab improved work productivity among patients with moderate to severe plaque psoriasis in three manufacturer-sponsored phase III clinical trials, according to a report published online March 7 in JAMA Dermatology.
In previous studies, many adults with plaque psoriasis have reported that...
Source: Skin and Allergy News - Category: Dermatology Source Type: news
More News: Allergy | Allergy & Immunology | Clinical Trials | Dermatology | Psoriasis | Skin | Study